Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin Dosing in Children with GHD and ISS
NCT00262249Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2000
- Primary completion
- May 2004
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), Idiopathic Short Stature (ISS), sponsored by Novo Nordisk. Started Aug 2000; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT00262249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262249.